News
Information, updates and press releases issued by Collaborations Pharmaceuticals.
Collaborations Pharmaceuticals, Inc. Announce A Phase I SBIR Award From NIEHS/NIH To Develop Machine Learning Software Approaches To Predict Acetylcholinesterase Inhibition
Raleigh – The National Institute of Environmental Health Sciences (NIEHS) has awarded $256,385 to Collaborations Pharmaceuticals, Inc. (CPI) to develop new machine learning models for prediction of acetylcholinesterase inhibition.
Collaborations Pharmaceuticals, Inc. Announce A Phase IIB SBIR Award From NIGMS/NIH To Develop Assay Central As A Machine Learning Software Suite
Raleigh – The National Institute of General Medical Sciences (NIGMS) has awarded $1,709,804 to Collaborations Pharmaceuticals, Inc. (CPI) to develop new capabilities in their Assay Central® machine learning software that will be applied to drug discovery research.
Three Common Antiviral Drugs Potentially Effective Against COVID-19
An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19.